STOCK TITAN

Organigram Global Inc Stock Price, News & Analysis

OGI Nasdaq

Welcome to our dedicated page for Organigram Global news (Ticker: OGI), a resource for investors and traders seeking the latest updates and insights on Organigram Global stock.

Organigram Holdings Inc (OGI) is a leading Canadian licensed cannabis producer specializing in premium medical and recreational products through advanced indoor cultivation. This news hub provides investors and industry observers with essential updates on OGI's operational developments, regulatory compliance, and market positioning.

Track official press releases covering quarterly earnings, product innovations, strategic partnerships. Access timely updates on regulatory milestones and cultivation advancements within Canada's dynamic cannabis sector. Our curated collection ensures transparent monitoring of OGI's financial performance and brand portfolio growth.

Key updates include medical cannabis research initiatives, recreational market expansions, and sustainability efforts. Bookmark this page for centralized access to OGI's corporate communications, enabling informed analysis of their market leadership in organic cannabis production.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.73%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.7%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-19.59%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.63%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.59%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.12%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.78%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.2%
Tags
none
Rhea-AI Summary

Organigram Holdings (NASDAQ: OGI) reported strong financial results for Q2 Fiscal 2023, achieving net revenue of $39.5 million, a 24% increase from $31.8 million in the same quarter last year. The adjusted gross margin improved to $13.4 million (34%), up from $8.3 million (26%). Notably, the company posted an adjusted EBITDA of $5.6 million, marking the fifth consecutive quarter of positive results, compared to $1.6 million in Q2 Fiscal 2022. Despite facing pricing pressures, particularly in large format flower SKUs, Organigram anticipates continued growth, with expectations for higher revenues in Q3 Fiscal 2023 driven by innovation and expanded product lines.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.41%
Tags

FAQ

What is the current stock price of Organigram Global (OGI)?

The current stock price of Organigram Global (OGI) is $1.29 as of June 20, 2025.

What is the market cap of Organigram Global (OGI)?

The market cap of Organigram Global (OGI) is approximately 196.8M.
Organigram Global Inc

Nasdaq:OGI

OGI Rankings

OGI Stock Data

196.81M
90.39M
34.41%
6.48%
4.28%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Canada
Toronto